|
FNTB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.960800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.235200E-01 |
| Normal-vs-Stage2 |
2.688200E-01 |
| Normal-vs-Stage3 |
1.135160E-01 |
| Normal-vs-Stage4 |
2.458400E-01 |
| Stage1-vs-Stage2 |
1.020610E-01 |
| Stage1-vs-Stage3 |
1.577840E-01 |
| Stage1-vs-Stage4 |
4.160400E-01 |
| Stage2-vs-Stage3 |
1.855910E-02 |
| Stage2-vs-Stage4 |
5.023700E-02 |
| Stage3-vs-Stage4 |
7.954400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.865600E-01 |
| Normal-vs-AfricanAmerican |
3.472800E-01 |
| Normal-vs-Asian |
2.022600E-01 |
| Caucasian-vs-AfricanAmerican |
2.440000E-01 |
| Caucasian-vs-Asian |
3.115600E-01 |
| AfricanAmerican-vs-Asian |
7.096400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.013600E-01 |
| Normal-vs-Female |
5.016400E-01 |
| Male-vs-Female |
9.719000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.201400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.583200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.601800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.683000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.632600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.778000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.158000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.389000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.189400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.626200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.575700E-02 |
| Classical-VS-Follicular |
5.107000E-01 |
| Classical-VS-Other |
9.119000E-01 |
| Classical-VS-Normal |
9.482600E-01 |
| Tall-VS-Follicular |
2.469800E-01 |
| Tall-VS-Other |
5.181200E-01 |
| Tall-VS-Normal |
6.942500E-02 |
| Follicular-VS-Other |
7.391200E-01 |
| Follicular-VS-Normal |
5.501000E-01 |
| Other-VS-Normal |
9.241800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.938400E-01 |
| Normal-vs-N1 |
1.830260E-02 |
| N0-vs-N1 |
4.441500E-02 |
|
|
